Literature DB >> 2521956

In vitro holding and PLD repair. I. On the contribution of mitotic non-quiescence in plateau-phase Chinese hamster V79 cells.

A F Stevenson1, C S Lange.   

Abstract

The Stationary or Plateau-Phase of commonly used rodent cell lines like the V79 are often assumed to be quiescent (non-mitotic). An analysis of cell turnover in V79 plateau-phase cultures through BrUdR-incorporation combined with FUdR-block and light exposure (S-phase cytocide) revealed such cultures to be in a state of kinetic equilibrium. Even when the state of maximal permissible density was acquired, at least 50% of the population of cells were cycling within the time for one population doubling. Attempts at holding the cells from cycling (through nutrient-depletion and serum-privation) were unsuccessful, although the turnover-rate was reduced. Our assays for X-irradiated clonogenic survivors after attempted holding combined with delayed plating (DP) showed differences in the survival curves for exponentially growing and confluent cultures. Elimination of cycling cells by S-phase cytocide removed these differences. Since a significant fraction of plateau-phase cells are not mitotically quiescent (Q), one must eliminate the proliferating (P) fraction if one wishes to examine the PLDR of the Q cells. For V79 cells, removal of the P cells eliminates the higher survival (usually interpreted as Q cell PLDR) of plateau-phase cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521956     DOI: 10.1007/bf01209720

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  26 in total

1.  Letter: Intracellular cyclic AMP levels and radiosensitivity in synchronized V-79 cells.

Authors:  S Lehnert
Journal:  Radiat Res       Date:  1975-11       Impact factor: 2.841

2.  Quantitative aspects of repair of potentially lethal damage in mammalian cells.

Authors:  G Iliakis; W Pohlit
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1979-12

3.  Intracellular cyclic AMP concentration responds specifically to growth regulation by serum.

Authors:  J Oey; A Vogel; R Pollack
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

4.  Potentially lethal damage versus sublethal damage: independent repair processes in actively growing Chinese hamster cells.

Authors:  H Utsumi; M M Elkind
Journal:  Radiat Res       Date:  1979-02       Impact factor: 2.841

5.  Factors influencing the repair of potentially lethal radiation damage in growth-inhibited human cells.

Authors:  J B Little
Journal:  Radiat Res       Date:  1973-11       Impact factor: 2.841

6.  Repair of sub-lethal and potentially lethal radiation damage in plateau phase cultures of human cells.

Authors:  J B Little
Journal:  Nature       Date:  1969-11-22       Impact factor: 49.962

7.  The shape of dose-survival curves for mammalian cells and repair of potentially lethal damage analyzed by hypertonic treatment.

Authors:  W Pohlit; I R Heyder
Journal:  Radiat Res       Date:  1981-09       Impact factor: 2.841

8.  Split-dose recovery is due to the repair of DNA double-strand breaks.

Authors:  D Frankenberg; M Frankenberg-Schwager; R Harbich
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1984-11

9.  Repair of potentially lethal damage in unfed plateau phase cultures of Ehrlich ascites tumour cells. II. Monolayer cultures.

Authors:  G Iliakis
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1980-06

10.  Fixation of potentially lethal radiation damage by post-irradiation exposure of Chinese hamster cells to 0.5 M or 1.5 M NaCl solutions.

Authors:  G P Raaphorst; W C Dewey
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1979-10
View more
  1 in total

1.  In vitro holding and PLD-repair: II. A flow cytometric and electron microscopic analysis of some mammalian cell lines.

Authors:  A F Stevenson; T Palackal; C S Lange
Journal:  Radiat Environ Biophys       Date:  1989       Impact factor: 1.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.